Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 93,035 | 110,930 | 75,154 | 61,897 | 58,535 |
| Marketable Securities | 229,761 | 143,600 | 244,383 | 260,345 | 312,166 |
| Receivables | 80,134 | 82,984 | 38,718 | 34,381 | 27,116 |
| Inventories | 5,875 | 5,548 | 4,090 | 3,932 | 6,200 |
| TOTAL | $437,565 | $371,110 | $379,567 | $374,171 | $416,702 |
| Non-Current Assets | |||||
| PPE Net | 4,022 | 4,320 | 4,561 | 4,853 | 5,336 |
| Intangibles | 113,868 | 109,435 | 105,607 | 103,816 | 103,974 |
| Other Non-Current Assets | 49,736 | 53,716 | 65,574 | 65,959 | 68,113 |
| TOTAL | $167,626 | $167,471 | $175,742 | $174,628 | $177,423 |
| Total Assets | $605,191 | $538,581 | $555,309 | $548,799 | $594,125 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,800 | 18,225 | 19,134 | 15,374 | 23,534 |
| Accrued Expenses | 126,035 | 105,762 | 81,682 | 77,108 | 86,028 |
| Other current liabilities | 3,194 | 5,353 | 14,291 | 15,757 | 17,106 |
| TOTAL | $159,904 | $135,074 | $189,540 | $182,457 | $200,751 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 330,459 | 329,943 | 333,022 | 333,519 | 334,297 |
| TOTAL | $330,459 | $329,943 | $333,022 | $333,519 | $334,297 |
| Total Liabilities | $490,363 | $465,017 | $522,562 | $515,976 | $535,048 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 92,242 | 89,472 | 89,139 | 88,805 | 88,740 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -1,472,713 | -1,475,442 | -1,501,148 | -1,488,393 | -1,447,167 |
| Other shareholders' equity | -1,189 | -1,054 | -812 | -843 | -80 |
| TOTAL | $114,828 | $73,564 | $32,747 | $32,823 | $59,077 |
| Total Liabilities And Equity | $605,191 | $538,581 | $555,309 | $548,799 | $594,125 |